Sofwave

Sofwave is a global aesthetic medicine company that specializes in non-invasive ultrasound technology for skin rejuvenation and muscle toning. Founded in 2015 in Israel, the company is headquartered in California and is publicly traded on the Tel Aviv Stock Exchange. Sofwave develops an FDA-cleared ultrasound system that targets the mid-dermal layer of the skin to improve facial lines, wrinkles, and skin laxity. The company offers a range of treatments, including non-invasive facial procedures that lift eyebrows and reduce fine lines, as well as body treatments that address skin laxity and muscle toning. Sofwave's proprietary SUPERB™ technology delivers precise ultrasound energy to stimulate collagen and elastin production, while its Pure Impact™ system provides muscle toning through bio-electrical stimulation. The treatments are designed for safety and efficacy, appealing to dermatologists and aesthetic clinics, as well as patients seeking effective anti-aging solutions without surgery or downtime.

• Employees 130
• Founded 2015
• Annual Revenue $59651000
• Total Funding $58400000